YES, HE SAID THE CROHNS COLITIS STUDY DATA WAS VERY POSITIVE. I BELIEVE WE SHALL GET ANNOUNCEMENT OUT OF NOWHERE ON THIS ONE DAY. MY BET IS THAT TAKEDA MAKE A PARTNERSHIP DEAL WITH MESOLAST FOR THIS INDICATION. AN EX MESOBLAST PERSON IS RUNNING THIS DIVISION WITHIN TAKEDA.
Ann: CEO Presentation to 2023 Annual General Meeting, page-11
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.5¢ |
Change
0.025(2.63%) |
Mkt cap ! $1.098B | |||
| Open | High | Low | Value | Volume |
| 94.5¢ | 98.0¢ | 93.5¢ | $2.730M | 2.832M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 30 | 107643 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 59568 | 22 |
View Market Depth
| Last trade - 14.53pm 12/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |